No abstract available.
Mycobacterium bovis* ; Recurrence*

No abstract available.
Carcinoma, Renal Cell* ; Neoplasm Metastasis*

No abstract available.
Carcinoma, Renal Cell* ; Neoplasm Metastasis*

No abstract available.
Actinomycosis*

No abstract available.
Actinomycosis*

No abstract available.
Diabetes Insipidus, Nephrogenic* ; Urinary Bladder*

Between February 8, 1990 and August 31, 1992, 12 renal units in 11 pediatric patients were treated by extracorporeal shock wave lithotripsy(ESWL) with the EDAP LT-01 + lithotriptor.The results were obtained as follows: 1. The sex ratio was 1.2:1, and the average patient age was 8.5 years with a range of 16 months to 15 years. 2. The locations of stones were renal without staghorn calculi in 1 renal units (33.3%), staghorn calculi in 2 (16.7%). upper ureter in 2(16.7%) and lower ureter in 4 renal units(33.3%). The average stone size was 16.8 mm with a range or 5 mm to 50 mm. 3. The factors predisposing to stone formation were urinary tract infection in 4 patients (36.4%), hypercalciuria in 1 (9.1%), hypoplastic kidney in 1 (9.1%), incomplete duplicated ureter in 1 (9.1%) and unknown factor in 4 (36.4%). 4. Or the 11 patients, 2 patients required I.V. anesthesia, 1 patient required epidural anesthesia and 8 patients were treated without any type of anesthesia. 5. The average number of treatment were 5.1 sessions and average storage required was 22.2 in one session. The average treatment time was 43 minutes. 6. The success rate of treatment-ended 11 renal units (complete removal of stones) were 90.9% 7. Comparing the results of ESWL in the treatment of urolithiasis in adult and children, the average storage of treatment was almost equal in both groups, but the time and numbers of treatment required in children was greater. Therefore, we conclude that extracorporeal shock wave lithotripsy with EDAP LT-01 + lithotryplor is considered to be a safe and effective procedure for treatment of urinary stones in child.
Adult ; Anesthesia ; Anesthesia, Epidural ; Calculi ; Child* ; Humans ; Hypercalciuria ; Kidney ; Lithotripsy* ; Sex Ratio ; Shock* ; Ureter ; Urinary Calculi ; Urinary Tract Infections ; Urolithiasis

To determine whether the relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostatic hyperplasia, we measured the percentage of stroma and gland by quantitative morphometric analysis in the prostate adenomas from men with symptomatic and asymptomatic BPH. Prostate adenomas were obtained from 9 men with asymptomatic BPH undergoing cysto-prostatectomy for invasive transitional cell carcinoma of the bladder (group 1), 15 with symptomatic BPH undergoing transurethral resection of the prostate and 5 with symptomatic BPH undergoing open prostatectomy( <60g : group 2a), and 15 with symptomatic BPH undergoing open prostatectomy( >= 60g: group 2b). The results obtained were as follows. 1. The prostate adenomas from group 1, 2a and 2b contained 57.1 %, 68.2% and 68.8% of stroma and 19.69t, 14.3% and 13.2% of epithelium and 23.3%, 17.5% and 18.0% of glandular lumen, respectively. The difference in percentage of stroma, epithelium and glandular lumen in the prostate adenoma from men with symptomatic and asymptomatic BPH were statistically significant(P <0.05). 2. The prostate adenomas from 24 men with modified Boyarsky obstructive symptom scoring over 10 were compared with 11 men with scores less than 10. The results were 68.2% vs. 69.3%, 13.8% vs. 13.5% and 18.0% vs. 17.2% of stroma, epithelium and glandular lumen, respectively ( P>0.1). 3. The prostate adenomas from 19 men with modified Boyarsky irritative symptom scoring over 7 were compared with 16 men with scores less than 7. The results were 67.6% vs. 69.9%, l3.8% vs. 14.1% and l8.0% vs. 16.2% of stroma, epithelium and glandular lumen, respectively ( P>0.1) . In conclusion, the prostate adenomas from men with symptomatic BPH were composed of more proportion of stroma and lesser proportion of epithelium and glandular lumen than those from men with symptomatic BPH. The histological composition of prostate adenomas were not related to the severity of obstructive or irritative symptom.
Adenoma ; Carcinoma, Transitional Cell ; Epithelium ; Humans ; Hyperplasia ; Male ; Prostate ; Prostatic Hyperplasia* ; Urinary Bladder

Between February 1990 and February 1993, Radiolucent stones of 27 renal units in 22 patients were treated by extracorporeal shock wave lithotripsy(ESWL) using the EDAP LT-01 +. Intravenous urography was done in all patients for the diagnosis of radiolucent stones. Retrograde pyelography, ultrasonography and/or computed tomography was done, if needed. The locations of stones were kidney in 11(40.7%), upper ureter in 8(29.6%), lower ureter in 6(22.2%), bladder in 1(3.7%), ureteropelvic junction in 1(3.7%). The average stone size was 10.9mm with a range of 5 to 32mm in maximum diameter. The average numbers of treatment were 2.7 sessions and average storage required was 34.8 in one session. The average treatment time was 40.4 minutes. All the patients showed complete removal of all calculous materials. Of 17 urinary stones analysed by chemical method, 8(47.1%) were composed of uric acid, 5(29.4%) of uric acid and calcium, 3 of phosphate and 1 of carbonate and phosphate. Therefore, we conclude that ESWL with EDAP LT-01 + lithotriptor is considered to be a effective noninvasive procedure for treatment of radiolucent stones.
Calcium ; Carbon ; Diagnosis ; Humans ; Kidney ; Lithotripsy* ; Shock* ; Ultrasonography ; Ureter ; Uric Acid ; Urinary Bladder ; Urinary Calculi ; Urography

PURPOSE: A retrospective analysis was performed to investigate the factors that affect stone recurrence in patients who were stone-free after extracorporeal shock wave lithotripsy(SWL). MATERIALS AND METHODS: From February 1990 to December 1992, 1039 patients were treated by SWL with EDAP LT-01+ lithotriptor. Among them 200 patients were followed up at 60 months. Fifty eight(29.0%) of 200 patients had recurrent stone after SWL. We analysed the patients according to patient age, sex, location, multiplicity and size of the original stones, serum calcium and uric acid level, urinary calcium and uric acid level at presentation, anatomical abnormality and pyuria after SWL as possible factors affecting stone recurrence. RESULTS: Mean age of the patients was 43.6 years(range 7 to 81) and there were 115 male and 85 female patients with sex ratio 1.35:1. Age and sex did not affect stone recurrence. The recurrence rates according to the stone location were 100%(1/1) for staghorn calculi, 28.6%(2/7) for pelvic stones, 26.2%(16/61) for single calyceal stone, 47.8%(11/23) for multiple calyceal stones and 29.7%(41/138) for ureteral stones. Stone location did not affect stone recurrence. 16(47.0%) of 34 renal units with multiple stones had recurrent stones, whereas 55(28.1%) of 196 renal units with single stone recurred. Multiplicity of the stone was the risk factor for stone recurrence(p<0.05). The stone size(renal unit) of less than 20mm were identified in 213 and 64(30.0%) of them had recurrent stones, whereas stone size(renal unit) of more than 20mm were identified in 17 and 7(41.2%) of them had recurrent stones. More than 20mm of the stone size was the risk factor for stone recurrence(p<0.05). Hypercalcemia, hyperuricemia, hypercalciuria, and hyperuricosuria did not affect stone recurrence. 14(28.6%) of 49 patients who had pyuria after SWL had recurrent stones, whereas sterile urine after SWL were noted in 151 and 44(29.1%) of them had recurrent stones. Pyuria after SWL did not affect stone recurrence. Anatomical abnormality was noted in 5 patients and 4(80%) of them showed recurrence, but there was no statistical significance due to small populations. CONCLUSIONS: Multiplicity and size of the stones were the risk factor for stone recurrence. But patient age, sex, location of the original stones, serum calcium and uric acid level, urinary calcium and uric acid level at presentation and pyuria after SWL did not affect stone recurrence.
Calcium ; Calculi ; Female ; Humans ; Hypercalcemia ; Hypercalciuria ; Hyperuricemia ; Lithotripsy* ; Male ; Pyuria ; Recurrence* ; Retrospective Studies ; Risk Factors ; Sex Ratio ; Shock* ; Ureter ; Uric Acid